Korean J Pediatr.  2009 Jan;52(1):50-55. 10.3345/kjp.2009.52.1.50.

The outcomes of retinopathy of prematurity in relation to duration of low dose oxygen therapy

Affiliations
  • 1Department of Pediatrics, Daegu Fatima Hospital, Daegu, Korea. sgleeped@korea.com

Abstract

PURPOSE
This study aimed to determine the influence of low-dose oxygen (FiO2 <25%) therapy through nasal cannulae on the progress and prognosis of retinopathy of prematurity (ROP) as well as methods of preventing ROP.
METHODS
Our subjects comprised premature infants (gestation period <37 weeks; birth weight <1,750 g) born in Daegu Fatima Hospital between February 1,2001 and January 31,2006. We retrospectively reviewed and analyzed the medical records of 273 patients who were available for eye examination and follow up over 6 months.
RESULTS
The factors maximally influencing the occurrence of ROP were low gestation age and low birth weight. We observed that the incidence of ROP increased with the increasing duration of low-dose oxygen therapy. ROP onset was delayed during ongoing oxygen therapy; however, rapid progression of ROP occurred after the discontinuation of oxygen therapy among premature infants up to the prethreshold stage.
CONCLUSION
To prevent of occurrence of severe ROP and its rapid progression, the period of low-dose oxygen therapy needs to be shortened. Moreover, frequent eye examinations should be performed after the discontinuation of oxygen therapy.

Keyword

Retinopathy of prematurity; Risk factors; Low dose oxygen therapy; Lung disease; Chronic

MeSH Terms

Birth Weight
Catheters
Diterpenes
Eye
Follow-Up Studies
Humans
Incidence
Infant, Low Birth Weight
Infant, Newborn
Infant, Premature
Lung Diseases
Medical Records
Oxygen
Pregnancy
Prognosis
Retinopathy of Prematurity
Retrospective Studies
Risk Factors
Diterpenes
Oxygen
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr